SRTS
Sensus Healthcare·NASDAQ
--
--(--)
--
--(--)
1.72 / 10
Underperform
SRTS has weak fundamentals, scoring only 1.7/10. Key concerns include negative asset-to-market and revenue-to-market ratios, low profitability margins, and suboptimal cash flow positioning. However, the interest coverage ratio is healthy at 15.48%, providing some buffer. Overall, the financial picture suggests selective investment only under defensive mandates.
Analysis Checks(6/10)
Revenue-MV
Value-0.48
Score0/3
Weight17.13%
1M Return-3.84%
Value-0.48
Score0/3
Weight17.13%
1M Return-3.84%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight7.85%
1M Return-1.71%
Value100.00
Score2/3
Weight7.85%
1M Return-1.71%
Cash-UP
Value-0.85
Score2/3
Weight19.13%
1M Return-4.86%
Value-0.85
Score2/3
Weight19.13%
1M Return-4.86%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight8.85%
1M Return-1.95%
Value15.48
Score2/3
Weight8.85%
1M Return-1.95%
Cash-MV
Value-0.17
Score1/3
Weight21.02%
1M Return-5.64%
Value-0.17
Score1/3
Weight21.02%
1M Return-5.64%
ROA (%)
Value-7.56
Score2/3
Weight1.81%
1M Return-0.39%
Value-7.56
Score2/3
Weight1.81%
1M Return-0.39%
Net income-Revenue
Value-0.17
Score1/3
Weight11.08%
1M Return-2.55%
Value-0.17
Score1/3
Weight11.08%
1M Return-2.55%
Annualized net profit margin on total assets (%)
Value-10.08
Score2/3
Weight1.81%
1M Return-0.39%
Value-10.08
Score2/3
Weight1.81%
1M Return-0.39%
Asset-MV
Value-0.50
Score1/3
Weight3.09%
1M Return-0.63%
Value-0.50
Score1/3
Weight3.09%
1M Return-0.63%
Net profit / Total profit (%)
Value68.65
Score2/3
Weight8.24%
1M Return-1.71%
Value68.65
Score2/3
Weight8.24%
1M Return-1.71%
Revenue-MV
Value-0.48
Score0/3
Weight17.13%
1M Return-3.84%
Value-0.48
Score0/3
Weight17.13%
1M Return-3.84%
ROA (%)
Value-7.56
Score2/3
Weight1.81%
1M Return-0.39%
Value-7.56
Score2/3
Weight1.81%
1M Return-0.39%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight7.85%
1M Return-1.71%
Value100.00
Score2/3
Weight7.85%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight11.08%
1M Return-2.55%
Value-0.17
Score1/3
Weight11.08%
1M Return-2.55%
Cash-UP
Value-0.85
Score2/3
Weight19.13%
1M Return-4.86%
Value-0.85
Score2/3
Weight19.13%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-10.08
Score2/3
Weight1.81%
1M Return-0.39%
Value-10.08
Score2/3
Weight1.81%
1M Return-0.39%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight8.85%
1M Return-1.95%
Value15.48
Score2/3
Weight8.85%
1M Return-1.95%
Asset-MV
Value-0.50
Score1/3
Weight3.09%
1M Return-0.63%
Value-0.50
Score1/3
Weight3.09%
1M Return-0.63%
Cash-MV
Value-0.17
Score1/3
Weight21.02%
1M Return-5.64%
Value-0.17
Score1/3
Weight21.02%
1M Return-5.64%
Net profit / Total profit (%)
Value68.65
Score2/3
Weight8.24%
1M Return-1.71%
Value68.65
Score2/3
Weight8.24%
1M Return-1.71%
Is SRTS undervalued or overvalued?
- SRTS scores 1.72/10 on fundamentals and holds a Premium valuation at present. Backed by its -8.51% ROE, -8.44% net margin, -97.62 P/E ratio, 1.62 P/B ratio, and -131.58% earnings growth, these metrics solidify its Underperform investment rating.
